Super fast tuberculosis diagnosis and sensitivity testing method
OwnerRobert S. Ledleyinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerRobert S. Ledleyinventor
Estimating the term…
Very rapid diagnosis and sensitivity testing can significantly stem the growing Tuberculosis epidemic in the United States, caused by susceptible AIDs patients and the occurrence of antibiotic resistant mycobacilli. Thus I have invented an automated computerized microscope, the ATBD unit, and slide module to diagnose and test patient's sputum by examining individual living mycobacteria from the patient sample with no culturing required. The diagnosis and sensitivity testing is accomplished in minutes or hours, instead of the current weeks to months. The system inserts a plasmid, specific for M. tuberculosis, carrying the luciferase gene into the mycobacteria by improved electroporesis on the slide. Luminescence indicates tuberculosis. Then the mycobacteria are bathed in antibiotics, and if the luminescence is not turned off, the patient's bacteria are resistant. A phage carrying the luciferase gene can also be used to infect the M.TB. Finally, the invention can be applied to any mycobacteriological infection to do diagnosis sensitivity testing even when the species is not known.
An apparatus for improving the efficiency of electroporesis comprising:
An Apparatus for mycobacterum infection diagnosis comprising:
An apparatus for mycobacterum antibiotic sensitivity testing comprising:
A method for Mycobacterium infection diagnosis using individual mycobacterial cells comprising:
A method for determining Mycobacterium antibiotic sensitivity testing comprising:
An automated pattern recognition apparatus for recognizing mycobacterium in the field of view comprising:
An apparatus for improving the efficiency of the electroporesis process on a specimen of suspended microorganisms comprising:
An apparatus for effectuating the fast Mycobacterium diagnosis and sensitivity testing comprising:
An apparatus for enabling both immunofluorescence followed by luminescence to be used for identifying a microorganism and then for antibiotic sensitivity testing of microorganisms comprising:
Dependencies are inferred from the claim text.